Blarcamesine

blarcamesine hydrochloride · Anavex Life Sciences Corp.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Blarcamesine, covering 2026-03-27 to 2026-03-27. Get the full timeline:

Most recent: EMA Application withdrawn: Blarcamesine Anavex (blarcamesine hydrochloride)